Altogether these findings demonstrated that CDC42 silences the TSG CACNA2D2 in SW620 cells in vitro and in vivo confirming a transcriptional molecular link between the tumorigenic effect of CDC42 and the silencing of the TSG CACNA2D2 in CRC observed in patients. The gene discussed is CACNA2D2; the disease is colorectal carcinoma.